These novel findings suggest that micro‐Exo can effectively target and accumulate in CD86‐positive microglia in ischemic regions, offering a promising strategy for enhancing the therapeutic efficacy of exosome‐based senolytic delivery treatments for ischemic stroke. The gene discussed is CD86; the disease is ischemic stroke.